As this news item indicates, some healthcare companies are starting to shift clinical services and decision making on medical care overseas, primarily to India and the Philippines. Is this a good strategy for these companies?
What are the pros and cons of this strategic decision?
Who would make a strategic decision of this magnitude in a healthcare company?